유방암 환자의 정신사회적 디스트레스에 대한 정신신체의학적 통합치료 = Psychosomatic Integrative Care for Psychosocial Distress of Patients With Breast Cancer

다국어 초록 (Multilingual Abstract)

Breast cancer is the most prevalent oncological disease among women. Various psychosocial distress is common at the diagnosis, treatment, and posttreatment phase of breast cancer. For the treatment of breast cancer, not only medical treatment but also psychosomatic integrative care will be needed. Patients with breast cancer may lead to increased vulnerability to stress, adjustment disorder, anxiety disorder, and depressive disorder, and these psychiatric diseases and conditions are associated with recurrence or exacerbation of breast cancer.
Psychosocial treatment of anxiety and depression could increase the quality of life of patients and decrease the recurrence and progression of breast cancer. In this article, we reviewed 5 clinical breast cancer survivorship guidelines focused on psychosomatic integrative care including psychosocial treatment and alternative treatment for psychosocial distress. Because 5 treatment guidelines were using various definitions of evidence, we confirmed evidence of various psychosocial treatments for patients with breast cancer based on the definition of evidence by the US Preventive Service Task Force (USPSTF) guideline. We also reviewed the effect size of psychosocial treatment for anxiety, depression, mood, and quality of life in patients with breast cancer. This article discusses the barrier to the delivery of psychosomatic integrative care and suggests integrative care planning for breast cancer.
Multi-disciplinary teams, patient’s needs assessment, information technology support, patient and caregiver engagement, planned periodic monitoring of psychosocial distress by a psychosomatic specialist or consultation-liaison psychiatrist are recommended as key features of a psychosomatic integrated care plan.

국문 초록 (Abstract)

유방암은 여성에서 가장 높은 유병율을 보이는 암으로, 진단과 치료과정 및 치료 후에도 다양한 정신사회적디스트레스가 자주 나타난다. 유방암 환자의 치료에는 의학적 치료뿐만 아니라 정신신체의학적 통합치료가필요하다. 유방암 환자는 스트레스, 불안장애, 우울장애, 적응 장애 등에 대한 취약성이 증가하고, 이러한 정신장애는 유방암의 악화 또는 재발과 연관이 있다. 유방암 환자의 불안과 우울에 대한 정신사회적 치료는 환자의삶의 질을 증진시키고, 유방암의 재발과 악화를 감소시킨다. 본 연구에서는 5편의 유방암 치료 가이드라인에서정신사회적 디스트레스에 대한 정신사회적 치료와 대체의학적 치료가 포함된 정신신체의학적 통합치료 부분에초점을 맞추어 논의하였다. 5편의 가이드 라인에서 사용한 서로 다른 근거 기준은 US Preventive Service Task Force (USPSTF) 기준에 맞춰 연구자들이 평가하여 근거를 기술하였다. 또한 유방암 환자의 불안, 우울, 기분, 삶의 질에 대한 정신사회적 치료의 효과 크기를 요약하였고, 정신신체의학적 통합치료 서비스 제공에 대한 장벽과 이에 대한 대안을 제시하였다. 다학제 팀을 구성하고, 환자 요구도를 조사하며, 정신사회적 치료의 정보를환자에게 제공하여 환자와 가족이 참여하는 것이 중요하다. 또한 준비된 계획에 따라 정기적으로 정신사회적디스트레스를 평가하고, 정신신체의학 전문가 또는 자문조정 정신건강의학과 의사에 의한 정신신체의학적 통합치료가 환자에게 제공되는 것이 가장 중요하다.

참고문헌 (Reference)

1 Stanton AL, "What happen now? Psychosocial care for cancer survivors after medical treatment completion" 30 : 1215-1220, 2012

2 Post KE, "Web based survivorship interventions for women with breast cancer : an integrative review" 25 : 90-99, 2016

3 Chae BJ, "Unmed needs and related factors or Korean breast cancer survivors : a multicenter, cross-sctional study" 19 : 839-, 2019

4 Sanson-Fisher R, "The unmet supportive care needs of patients with cancer. Supportive Care Review Group" 88 : 226-237, 2000

5 Zainal NZ, "The efficacy of mindfulness-based stress reduction on mental health of breast cancer patients : a meta-analysis" 22 : 1457-1465, 2013

6 Guarino A, "The effectiveness of psychological treatments in women with breast cancer : a systematic review and metaanalysis" 9 : 1-26, 2020

7 Brown ML, "The burden of illness of cancer : economic cost and quality of life" 22 : 91-113, 2001

8 Cohen J, "Statistical power analysis for behavioral science" Academic 1988

9 Hashemi SM, "Rrevalence of anxiety among breast cancer patients : a systematic reivew and meta-analysis" 27 : 166-178, 2019

10 Schmid-Büchi S, "Psychosocial problems and needs of posttreatment patients with breast cancer and their relatives" 15 : 260-266, 2011

11 Quality of Care and Health Outcomes, Australia, "Psychosocial clinical practice guidelines information, support and counselling for women with breast cancer"

12 Wang X, "Prognostic value of depression and anxiety on breast cancer recurrence and mortality : a systematic review and meta-analysis of 282, 203 patients" 25 : 3186-3197, 2020

13 Xin W, "Prevalence of posttraumatic stress disorder among breast cancer patients : a meta-analysis" 45 : 1533-1544, 2016

14 Dilworth S, "Patient and health professional’s perceived barriers to the delivery of psychosocial care to adults with cancer : a systematic review" 23 : 601-612, 2014

15 Mirosevic S, "Not just another meta-analysis”: sources of hetergogeneity in psychosocial treatment effect on cancer survival" 8 : 363-373, 2019

16 Quality of care and health outcomes committee, "Guidelines for the development and implementation of clinical practice guidelines"

17 Balouch A, "Global prevalence of depression among breast cancer patients : a systematic review and meta-analysis" 176 : 519-533, 2019

18 Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 conturies" 68 : 394-424, 2018

19 Beatty L, "Evaluating the efficacy of a self-guided Web-based CBT intervention for reducing cancerdistress : a randomised controlled trial" 24 : 1043-1051, 2016

20 Ferlay J, "Estimates of worldwide burden of cancer in 2008 : GLOBOCAN 2008" 127 : 2893-2917, 2010

21 Atema V, "Efficacy of Internet-based cognitive behavioral therapy for treatment-induced menopausal symptoms in breast cancer survivors : results of a randomized controlled trial" 37 : 809-822, 2019

22 Mehnert A, "Discussing the need for psychosocial care in oncology" 64 : 251-252, 2014

23 US Preventive Service Task Force, "Definitions of Grade system"

24 Giese-Davis J, "Decrease in depression symptoms is associated with longer survival in patietns with metastatic breast cancer : a secondary analysis" 29 : 413-420, 2011

25 Greenlee H, "Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer" 2014 : 346-358, 2014

26 Greenlee H, "Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment" 67 : 194-232, 2017

27 Harris SR, "Clinical practice guidelines for breast cancer rehabilitation : synthesis of guideline recommendation and qualitive appraisals" 118 : 2312-2324, 2012

28 "Cancer registry statistics in Korea 2016"

29 Eakin EG, "Awareness and barriers to use of cancer support and information resources by HMO patients with breast, prostate, or colon cancer : patient and provider perspectives" 10 : 103-113, 2001

30 Sutherland G, "Assessing the unmet supportive care needs of newly diagnosed patients with cancer" 18 : 577-584, 2009

31 Runowicz CD, "American cancer society/American society of clinical oncology breast cancer surviviorship care guideline" 66 : 43-73, 2016